0
Skip to Content
NEUTherapeutics
About
Team
Pipeline
Allopregnanolone
PhytoSERM
News
Publications
Allopregnanolone
PhytoSERM
Contact
NEUTherapeutics
About
Team
Pipeline
Allopregnanolone
PhytoSERM
News
Publications
Allopregnanolone
PhytoSERM
Contact
About
Team
Folder: Pipeline
Back
Allopregnanolone
PhytoSERM
News
Folder: Publications
Back
Allopregnanolone
PhytoSERM
Contact

Research Team.

Dr. Roberta Diaz Brinton, Ph.D., Founder and President

Dr. Roberta Diaz Brinton, Ph.D., Founder and President

John Rinehart, MBA, MA,     Chief Executive Officer

John Rinehart, MBA, MA, Chief Executive Officer

Gerson Hernandez, M.D., M.P.H, Chief Clinical Trials Officer

Gerson Hernandez, M.D., M.P.H, Chief Clinical Trials Officer

Dr. Kathy Rodgers, Ph.D.,        Chief Science Officer

Dr. Kathy Rodgers, Ph.D., Chief Science Officer

Mark Drew, Ph.D.,        Chief Operations Officer

Mark Drew, Ph.D., Chief Operations Officer

Claudia Lopez, B.S.,      Chief Compliance Officer

Claudia Lopez, B.S., Chief Compliance Officer

Home | About | Allopregnanolone Pipeline | PhytoSERM Pipeline | News | Allopregnanolone Publications | PhytoSERM Publications | Contact | Financial Conflict of Interest Policy

All content ©NeuTherapeutics 2023